DOI: 10.36347/sasjm.2022.v08i09.001

Pages: 588-593

Although radical cystectomy remains the standard treatment for muscle-invasive bladder cancer, concurrent chemoradiotherapy offers a curative option to patients medically unfit for radical surgery and an alternative conservative treatment for selected patients who are potential candidates for cystectomy. Pelvic irradiation techniques in the various pelvic cancers such as bladder cancer are most often accompanied by toxicity over the course and the long term, despite new advances in radiotherapy such as IMRT and VMAT. Which were still able to reduce the rate of acute and late toxicities after treatment? A good knowledge of these complications makes it possible to: detect them, treat them or better, prevent them for a better quality of life. Survival rates are poor for muscle-invasive bladder cancer, with around 45% of patients surviving for 5 years regardless of the type of treatment.